Patrick Finley, PharmD

Professor

Department of Clinical Pharmacy

Kaz Tsuruta

[email protected]

Phone: +1 415 502-8041

Fax: +1 415 476-6632

521 Parnassus Avenue

San Francisco, CA 94117

United States

Links

UCSF Profiles

Joint appointments

Volunteer Faculty, 1994-present, University of New Mexico College of Pharmacy

Educational programs

Site Coordinator, UCSF-LPPI, ZSFG PGY2 Psychiatric Pharmacy Residency Program

UCSF centers, institutes, and research programs

UCSF Women's Health Center of Excellence

UCSF Depression Center (NNDC affiliate)

External affiliations

American Pharmacists Association (APhA)

College of Psychiatric and Neurologic Pharmacists

What I do

I am a professor with the department of clinical Pharmacy and a Board Certified in Psychiatric Pharmacy (BCPP) with a strong interest in the pharmacological management of mood disorders, particularly in perinatal populations. I have additional expertise in the field of pharmacokinetics, particularly as it applies to potential drug interactions, and conducting epidemiological research relating to psychotropic medications. I am committed to optimizing the medical management of the mentally ill and remain actively involved with various professional organizations and the community at large to achieve this goal.

Departmental research area

clinical research

My research expertise

pharmacokinetics, psychopharmacology, psychiatric pharmacy, depression, Antidepressants, mood disorders, perinatal mood disorders, drug interactions, epidemiology, health services research

Clinical expertise

mood disorders, psychopharmacology

Degrees

PharmD, University of California, San Francisco, 1987

BA, Biology, University of California, Santa Barbara, 1983

Biography

Dr. Finley is a Professor of Clinical Pharmacy at UC San Francisco with a special interest in psychopharmacology and behavioral health. He became Board Certified in Psychiatric Pharmacy (BCPP) in 2007 and is a licensed medical provider at UCSF and a clinician in the depression clinic located at the Womens Health Center. He is a nationally recognized expert in the pharmacological management of mood disorders, with an emphasis on the treatment of mental illness in perinatal populations. He has additional expertise in the field of pharmacokinetics, particularly as it applies to potential drug interactions and associated toxicities with psychotropic medications. Dr. Finley also completed a certificate program in Outcomes Research and Epidemiology through the UCSF School of Medicine and has applied this training to conduct clinical and translational research using large databases (eg - California State Medicaid). He is a committed advocate to the cause of optimizing the medical treatment of the mentally ill and is actively involved in professional organizations and the community at large to promote safe and efficacious medication use.

Research keywords

Health Services Research
psychopharmacology
pharmacokinetics
Epidemiology
depression
drug interactions
Antidepressants
Perinatal Mood Disorders
Psychiatric Pharmacy
Mood Disorders
Program Evaluation
Lithium
pharmaceutical services
emotional intelligence
depression
Benzodiazepines
Adrenergic beta-Antagonists
Psychotropic Drugs
Cytochrome P-450 CYP2D6
Postpartum Depression
Antidepressive Agents
Drug Prescriptions
drug interactions
Hypnotics and Sedatives
Cytochrome P-450 CYP2D6 Inhibitors

Licensure and certifications

Licentiate in Pharmacy, California, 1987

Board Certified Psychiatric Pharmacist (BCPP), 1997

National Provider Identifier 1998

DEA Certification, License Number, 2005

1.	High Quality Peer Reviewer Award, Journal of Managed Care Pharmacy, 2012
2.	Apple Award for Teaching Excellence, UC San Francisco School of Pharmacy, 2010
3.	Apple Award for Teaching Excellence, UC San Francisco School of Pharmacy, 2009
4.	High Quality Peer Reviewer Award, Journal of Managed Care Pharmacy, 2008
5.	Apple Award for Teaching Excellence, UC San Francisco School of Pharmacy, 2008
6.	Dorfman Journal Paper Award, Academy of Psychosomatic Medicine, 2007
7.	High Quality Peer Reviewer Award, Journal of Managed Care Pharmacy, 2007
8.	Fellow, California Society of Health-System Pharmacists, 2005
9.	Presidential Honors Certificate, College of Psychiatric and Neurologic Pharmacists, 2002
10.	1st Place - Best Research Poster by Resident, American College of Clinical Pharmacy, 1999
11.	Rho Chi Honor Society, UC San Francisco School of Pharmacy, 1987

Publications

Shin J, Hills NK, Finley PR. Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction. Pharmacotherapy. 2020 06; 40(6):507-516.

Tamraz B, Reisner L, French AL, King ST, Fischl MA, Ofotokun I, Kashuba A, Milam J, Murphy K, Augenbraun M, Liu C, Finley PR, Aouizerat B, Cocohoba J, Gange S, Bacchetti P, Greenblatt RM. Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection. Pharmacotherapy. 2019 09; 39(9):899-911.

Avdagic K, Geier M, Coralic Z, Finley P. Evaluation of the Impact of a Multimodel Intervention on Prescribing Patterns of Sedative-Hypnotics in a Behavioral Health System. Prim Care Companion CNS Disord. 2018 May 31; 20(3).

Finley PR. Drug Interactions with Lithium: An Update. Clin Pharmacokinet. 2016 08; 55(8):925-41.

Finley PR, Brizendine L. Enhancing our understanding of perinatal depression. CNS Spectr. 2015 Feb; 20(1):9-10.

Geier ML, Hills N, Gonzales M, Tum K, Finley PR. Detection and treatment rates for perinatal depression in a state Medicaid population. CNS Spectr. 2015 Feb; 20(1):11-9.

El-Ibiary SY, Hamilton SP, Abel R, Erdman CA, Robertson PA, Finley PR. A pilot study evaluating genetic and environmental factors for postpartum depression. Innov Clin Neurosci. 2013 Sep; 10(9-10):15-22.

Finley PR, Bluml BM, Bunting BA, Kiser SN. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc (2003). 2011 Jan-Feb; 51(1):40-9.

Ng RC, Hirata CK, Yeung W, Haller E, Finley PR. Pharmacologic treatment for postpartum depression: a systematic review. Pharmacotherapy. 2010 Sep; 30(9):928-41.

Vogt EM, Finley PR. Heart of Pharmacy: a course exploring the psychosocial issues of patient care. Am J Pharm Educ. 2009 Dec 17; 73(8):149.

Finley PR, Bero L. Clarification of study and citation. Arch Intern Med. 2007 Dec 10; 167(22):2531; author reply 2531-2.

Lee KC, Ray GT, Hunkeler EM, Finley PR. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics. 2007 May-Jun; 48(3):205-10.

Finley PR. Antidepressants, suicide, and the FDA: a loose association. Ann Pharmacother. 2004 Oct; 38(10):1739-42.

Kemppainen JK, Levine R, Buffum M, Holzemer W, Finley P, Jensen P. Antiretroviral adherence in persons with HIV/AIDS and severe mental illness. J Nerv Ment Dis. 2004 Jun; 192(6):395-404.

Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003 Dec; 23(12):1634-44.

Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003 Sep; 23(9):1175-85.

Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003 May; 2(3):233-47.

Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002 Aug 15; 59(16):1518-26.

Finley PR. Atypical antipsychotics and tardive dyskinesia. J Manag Care Pharm. 2002 Jul-Aug; 8(4):291-2.

Del Paggio D, Finley PR, Cavano JM. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population. Clin Ther. 2002 May; 24(5):803-17.

Finley PR, Sommer BR, Corbitt JL, Brunson GH, Lum BL. Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic setting. Psychopharmacol Bull. 1998; 34(1):75-81.

Finley PR, O'Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996 Feb; 16(1):68-71.

Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995 Sep; 29(3):172-91.

Finley PR, Bogert CL, Alberts DS, Einspahr J, Earnest DL, Blackwell G, Girodias K. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May; 4(3):239-44.

Finley PR. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother. 1994 Dec; 28(12):1359-69.

Salmon SE, Crowley JJ, Grogan TM, Finley P, Pugh RP, Barlogie B. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study. J Clin Oncol. 1994 Nov; 12(11):2405-14.

Finley P, Warner D. Potential impact of valproic acid therapy on clozapine disposition. Biol Psychiatry. 1994 Oct 01; 36(7):487-8.

Bellamy WT, Odeleye A, Finley P, Huizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM. An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am J Pathol. 1993 Mar; 142(3):691-7.

Skála J, Witte C, Bruna J, Case T, Finley P. Chyle leakage after blunt trauma. Lymphology. 1992 Jun; 25(2):62-8.

Butman SM, Wild JC, Nolan PE, Fagan TC, Finley PR, Hicks MJ, Mackie MJ, Copeland JG. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant. 1991 May-Jun; 10(3):351-8.

Calvin S, Silva M, Weinstein L, Finley P, Witte M. Characterization of ascites present at cesarean section. Am J Perinatol. 1991 Mar; 8(2):99-102.

Brown MA, Morgan WJ, Finley PR, Scuderi P. Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis. Pediatr Pulmonol. 1991; 10(2):86-91.

Scuderi P, Finley PR, Shon BY, Udall JN, Roe DJ, Chong AS. Regulation of tumor necrosis factor secretion in leukocytes from alpha-1-antitrypsin deficient humans. Immunol Invest. 1990 Oct-Dec; 19(5-6):453-61.

Salmon SE, Tesh D, Crowley J, Saeed S, Finley P, Milder MS, Hutchins LF, Coltman CA, Bonnet JD, Cheson B. Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study. J Clin Oncol. 1990 Sep; 8(9):1575-84.

Stuntz ME, Witte MH, Witte CL, Way DL, Champsi JH, Finley PR. Effect of interleukin-2 on microvascular liquid and protein transport in the rat small intestine. Lymphology. 1990 Sep; 23(3):149-54.

Muir WS, Magee FP, Longo JA, Karpman RR, Finley PR. Comparison of ultrasonically applied vs. intra-articular injected hydrocortisone levels in canine knees. Orthop Rev. 1990 Apr; 19(4):351-6.

Calvin S, Weinstein L, Witte MH, Finley PR. Plasma levels of fibronectin and prostacyclin metabolite in peripartum preeclamptic women. Am J Perinatol. 1990 Apr; 7(2):125-9.

Durie BG, Stock-Novack D, Salmon SE, Finley P, Beckord J, Crowley J, Coltman CA. Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood. 1990 Feb 15; 75(4):823-30.

Christenson RH, Finley PR, Silverman LM. Immunochemical assays for IgG, IgA, IgM and transferrin compared. Clin Biochem. 1989 Aug; 22(4):271-6.

Scuderi P, Dorr RT, Liddil JD, Finley PR, Meltzer P, Raitano AB, Rybski J. Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. Eur J Immunol. 1989 May; 19(5):939-42.

Finley PR, Nolan PE. Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam. DICP. 1989 Feb; 23(2):151-2.

Sandyk R, Bamford CR, Binkiewicz A, Finley PR. Gonadotropin deficiency in Tourette's syndrome: a preliminary communication. Int J Neurosci. 1988 Sep; 42(1-2):121-5.

Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Petersen E, Slymen DJ, Salmon SE. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet. 1986 Dec 13; 2(8520):1364-5.

Levitt MA, Sullivan JB, Owens SM, Burnham L, Finley PR. Amitriptyline plasma protein binding: effect of plasma pH and relevance to clinical overdose. Am J Emerg Med. 1986 Mar; 4(2):121-5.

Finley PR, Ryan KJ. Office and clinic laboratories. Maintaining quality control. Am J Dis Child. 1986 Mar; 140(3):199.

Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR. Methotrexate: bioavailability and pharmacokinetics. Cancer Treat Rep. 1985 Jul-Aug; 69(7-8):833-8.

Bever FN, Finley PR, Fletcher C, Williams J. Liquid-chromatographic determination of vancomycin evaluated and improved. Clin Chem. 1984 Sep; 30(9):1586-7.

Lindsey D, Finley PR. Re: Myocardial contusion following nonfatal blunt chest trauma. J Trauma. 1984 Jun; 24(6):548.

Witte MH, Witte CL, Minnich LL, Finley PR, Drake WL. AIDS in 1968. JAMA. 1984 May 25; 251(20):2657.

Sadeh M, Stern LZ, Czyzewski K, Finley PR, Russell DH. Increased activities of MB and BB isozymes of creatine kinase in denervated neonatal and adult rat muscle. Exp Neurol. 1984 Mar; 83(3):640-5.

Sadeh M, Stern LZ, Czyzewski K, Finley PR, Russell DH. Alterations in creatine kinase, ornithine decarboxylase, and transglutaminase during muscle regeneration. Life Sci. 1984 Jan 30; 34(5):483-8.

Sampliner R, Perrier D, Powell R, Finley P. Influence of ascites on tobramycin pharmacokinetics. J Clin Pharmacol. 1984 Jan; 24(1):43-6.

Garewal H, Durie BG, Kyle RA, Finley P, Bower B, Serokman R. Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders. J Clin Oncol. 1984 Jan; 2(1):51-7.

Wirt DP, Grogan TM, Payne CM, Kummet TD, Durie BG, Finley PR, Rollins D. Phagocytic, lambda light chain, plasma cell myeloma. Am J Clin Pathol. 1983 Jul; 80(1):75-84.

Lund ME, Banner W, Finley PR, Burnham L, Dye JA. Effect of alcohols and selected solvents on serum osmolality measurements. J Toxicol Clin Toxicol. 1983 Apr; 20(2):115-32.

Nau H, Finley P, Williams J, Brendel K. Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirs. Biopharm Drug Dispos. 1983 Apr-Jun; 4(2):173-82.

Conrad KA, Byers JM, Finley PR, Burnham L. Lidocaine elimination: effects of metoprolol and of propranolol. Clin Pharmacol Ther. 1983 Feb; 33(2):133-8.

Finley PR, Williams RJ. Assay of cerebrospinal fluid protein: a rate biuret method evaluated. Clin Chem. 1983 Jan; 29(1):126-9.

Weinstein L, Anderson CF, Finley PR, Lichti DA. The in utero management of urinary outflow tract obstruction. J Clin Ultrasound. 1982 Nov-Dec; 10(9):465-8.

Schifman RB, Rivers SL, Finley PR, Thies C. RBC zinc protoporphyrin to screen blood donors for iron deficiency anemia. JAMA. 1982 Oct 22; 248(16):2012-5.

Fenster PE, Comess KA, Hanson CD, Finley PR. Kinetics of the digoxin-aspirin combination. Clin Pharmacol Ther. 1982 Oct; 32(4):428-30.

Hicks MJ, Heick M, Finley P, Gall EP, Minnich L, Williams RJ. Rheumatoid factor activity by rate nephelometry correlated with clinical activity in rheumatoid arthritis. Am J Clin Pathol. 1982 Sep; 78(3):342-5.

Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR. Cimetidine decreases theophylline clearance. Ann Intern Med. 1981 Jul; 95(1):68-9.

Finley PR, Dye JA, Williams RJ, Lichti DA. Rate-nephelometric inhibition immunoassay of phenytoin and phenobarbital. Clin Chem. 1981 Mar; 27(3):405-9.

Karpman RR, Weinstein PR, Finley PR, Karst-Sabin B. Serum CPK isoenzyme BB as an indicator of brain tissue damage following head injury. J Trauma. 1981 Feb; 21(2):148-51.

Schifman RB, Brumbaugh PF, Grover D, Finley PR, Harrow EJ. A cellulose acetate electrophoretic procedure evaluated for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1981 Jan; 27(1):175-8.

Schifman RB, Finley PR. Measurement of near-normal concentrations of erythrocyte protoporphyrin with the hematofluorometer: influence of plasma on "front-surface illumination" assay. Clin Chem. 1981 Jan; 27(1):153-6.

Finley PR, Williams RJ, Lichti DA. Evaluation of a new homogeneous enzyme inhibitor immunoassay of serum thyroxine with use of a bichromatic analyzer. Clin Chem. 1980 Nov; 26(12):1723-6.

Finley PR, Williams RJ, Griffith F, Lichti DA. Adaptation of the enzyme-multiplied immunoassay for methotrexate to the centrifugal analyzer. Clin Chem. 1980 Feb; 26(2):341-3.

Finley PR, Hicks MJ, Williams RJ, Hinlicky J, Lichti DA. Rate nephelometric measurement of rheumatoid factor in serum. Clin Chem. 1979 Nov; 25(11):1909-14.

Glasser L, Finley PR. Stability of solutions of human granulocyte lactate dehydrogenase stored at different temperatures. Transfusion. 1979 Nov-Dec; 19(6):756-60.

Lindsey D, Navin T, Finley P. Meaning of elevated CK-MB. Am Heart J. 1979 Sep; 98(3):405-6.

Finley PR. Changes in immunoglobulin control sera. Clin Chem. 1979 Aug; 25(8):1515.

Finley PR, Williams RJ, Lichti DA, Griffith F, Thies AC. Immunochemical determination of human immunoglobulins: use of kinetic turbidimetry and a 36-place centrifugal analyzer. Clin Chem. 1979 Apr; 25(4):526-30.

Finley PR, Williams RJ, Lichti DA, Thies AC. Evaluation of a new multichannel analyzer, "Astra-8". Clin Chem. 1978 Dec; 24(12):2125-31.

Lindsey D, Navin TR, Finley PR. Transient elevation of serum activity of MB isoenzyme of creatine phosphokinase in drivers involved in automobile accidents. Chest. 1978 Jul; 74(1):15-8.

Finley PR, Dye JA, Lichti DA, Byers JM, Williams RJ. A modified ion-selective electrode method for measurement of chloride in sweat. Am J Clin Pathol. 1978 Jun; 69(6):615-8.

Finley PR, Schifman RB, Williams RJ, Lichti DA. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem. 1978 Jun; 24(6):931-3.

Finley PR, Williams RJ. Evaluation of homogeneous enzyme immunoassay of serum thyroxine with use of bichromatic analysis. Clin Chem. 1978 Jan; 24(1):165-7.

Finley PR, Williams RJ. Methotrexate assay by enzymatic inhibition, with use of centrifugal analyzer. Clin Chem. 1977 Nov; 23(11):2139-41.

Finley PR, Willaims RJ, Lichti DF, Byers JM. Assay of phenobarbital: adaption of "EMIT" to the centrifugal analyzer. Clin Chem. 1977; 23(4):738-40.

Finley PR, Williams RJ, Byers JM. Immunochemical determination of human immunoglobulins with a centrifugal analyzer. Clin Chem. 1976 Jul; 22(7):1037-41.

Finley PR, Williams RJ, Byers JM. Assay of phenytoin: adaptation of "EMIT" to the centrifugal analyzer. Clin Chem. 1976 Jun; 22(6):911-4.

Finley PR. Hageman factor. Ann Clin Lab Sci. 1972 Jan-Feb; 2(1):37-9.

Finley PR. Hypergammaglobulinemia. Minn Med. 1970 Dec; 53(12):1241 passim.

Peterson RA, Krull PE, Finley P, Ettinger MG. Changes in antithrombin 3 and plasminogen induced by oral contraceptives. Am J Clin Pathol. 1970 Apr; 53(4):468-73.

Finley PR, Anderson F, Neese R. Electronic data processing in a private hospital laboratory. Am J Clin Pathol. 1967 Dec; 48(6):575-89.

FISCH RO, BERGLUND EB, BRIDGE AG, FINLEY PR, QUIE PG, RAILE R. METHEMOGLOBINEMIA IN A HOSPITAL NURSERY: A SEARCH FOR CAUSATIVE FACTORS. JAMA. 1963 Sep 07; 185:760-3.

DOSCHERHOLMEN A, FINLEY PR, HAGEN PS. Distribution of radioactivity in man after the oral ingestion of small test doses of radiolabeled cyanocobalamin. J Lab Clin Med. 1960 Oct; 56:547-54.